跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 79,608 条关于
“anti-PD-1 monoclonal antibody”
全部
79,608
临床试验
46,322
药物
11,685
机构
1,504
资讯
20,097
6个月前
Junshi Biosciences Achieves Regulatory Milestone with First Domestic Subcutaneous Anti-PD-1 Antibody Application in China
去年
CHMP Recommends Approval of Henlius and Intas' Serplulimab for ES-SCLC in Europe
去年
MHRA Approves Serplulimab as First Anti-PD-1 Therapy for Small Cell Lung Cancer in UK
4年前
Junshi Biosciences' Anti-CD112R Monoclonal Antibody, TAB009/JS009, Receives FDA IND Approval for Advanced Solid Tumors
去年
BeiGene Initiates Phase I Clinical Trial of BGB-A317 in China
11个月前
Anti-PD-1 Immunotherapy Shows Promise for Drug-Free HIV Control in Phase 1 Trial
上个月
Henlius Reports 2026 Interim Results: Serplulimab Becomes First Anti-PD-1 mAb Approved for Perioperative Gastric Cancer
去年
Henlius Receives Approval for HLX10 in China, Expanding Oncology Portfolio
去年
Henlius' Serplulimab Makes History as First PD-1 Inhibitor Approved in EU for Small Cell Lung Cancer
去年
UK MHRA Approves Junshi Biosciences' Toripalimab for Nasopharyngeal and Esophageal Cancers
第 1 页，共 2010 页
上一页
下一页
